About

Dr. Matteo Ferro is a leading urologic surgeon and researcher whose work sits at the intersection of minimally invasive surgery, artificial intelligence, and oncology. His primary research areas include robotic and laparoscopic surgery for prostate and kidney cancers, as well as the application of machine learning to improve prostate cancer patient management. Dr. Ferro has made landmark contributions to the field through large-scale, multi-institutional collaborative studies. His 2014 analysis of robotic versus laparoscopic simple prostatectomy has garnered 197 citations, while his 2021 work on AI and machine learning in prostate cancer care—a rapidly growing area—has already accumulated 157 citations. He is a key figure in the ROBUUST and ROSULA collaborative groups, which have produced highly cited, practice-shaping studies on nephroureterectomy and partial nephrectomy outcomes. Notably, his meta-analysis of over 87,000 nephroureterectomy cases (89 citations) and his multicenter analysis of robot-assisted partial nephrectomy for T2 renal tumors (147 citations) have helped define best practices in complex urologic oncology. Dr. Ferro’s work consistently bridges surgical technique, patient selection, and emerging technologies, making him a pivotal voice in modern urology.

Research Focus

Key Achievements

21
H-Index
56
Papers
1,568
Total Citations
28
Avg Citations/Paper
🏆 Most Cited Paper
Perioperative Outcomes of Robotic and Laparoscopic Simple Prostatectomy: A European–American Multi-institutional Analysis
197 citations · 2014
📈 Most Prolific Year: 2021 (12 Papers)
🤝 Key Collaborators: 537
🏛 Institutions: European Institute of Oncology, Istituti di Ricovero e Cura a Carattere Scientifico, Azienda Ospedaliero-Universitaria Careggi, University of Milan, University of Foggia, AOL (United States)

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago